Emirates Health Services, Johnson & Johnson to collaborate across medical specialties

The agreement specified three main areas of collaboration – educational programme and training courses, strategic solutions programme and public awareness programme.

The collaboration with Johnson & Johnson will set a framework for a more comprehensive data-driven partnership that aims to support hospitals and healthcare professionals, improve patient experience, and reduce the total cost of care, state news agency Wam reported.

The agreement, signed by Dr. Yousif Mohammed Al-Serkal, Director-General of EHS, and Loai Abu Elhawa, general manager – MedTech Gulf at Johnson & Johnson,  also calls for collaboration to implement public awareness programmes and campaigns covering various diseases such as obesity, cancer and atrial fibrillation.

Commenting on the agreement, Al-Serkal said it was aimed at supporting EHS’ efforts to provide innovative and sustainable health services to boost efficiency across the entire health system.

“This will set the stage for more ambitious advancements in healthcare systems at the local and international levels,” Al-Serkal said.

Marzina Collis, managing director at Johnson & Johnson, said the MoU would allow the company to exchange expertise and work closely with outstanding healthcare professionals and use advanced technologies to help develop their skills and attract more talent to this vital sector.

EHS and the US pharma major’s Middle East arms will work together to launch the ‘Silent Noise Campaign’ to raise awareness about and destigmatise mental health conditions – focusing particularly on schizophrenia and depression.

This campaign is in line with EHS’ strategy to drive positive change and combat stereotypes associated with mental health. The MoU outlines various areas of cooperation for EHS to work on with Johnson & Johnson (Middle East) Inc. and Johnson & Johnson Middle East FZ-LLC.